News

Published on 14 Jan 2024 on Zacks via Yahoo Finance

Why Avadel Pharmaceuticals (AVDL) Stock Might be a Great Pick


Article preview image

One stock that might be an intriguing choice for investors right now is Avadel Pharmaceuticals plc AVDL. This is because this security in the Medical - Drugs space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Medical - Drugs space as it currently has a Zacks Industry Rank of 72 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, Avadel Pharmaceuticals is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

NASDAQ.AVDL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript May 8, 2024 Avadel Phar...

Insider Monkey via Yahoo Finance 10 May 2024

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Is Expected To Breakeven In The Near Future

Avadel Pharmaceuticals plc (NASDAQ:AVDL) is possibly approaching a major achievement in its busin...

Simply Wall St. via Yahoo Finance 11 Apr 2024

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript March 4, 2024 Avadel Ph...

Insider Monkey via Yahoo Finance 5 Mar 2024

Avadel Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results - Avadel Pharmaceuticals...

Avadel Pharmaceuticals plc AVDL reported better-than-expected fourth-quarter revenue results and...

Benzinga 5 Mar 2024

Avadel wins patent suit, plans appeal on another

Avadel wins patent suit, plans appeal on another

Investing.com 3 Mar 2024

With 62% ownership, Avadel Pharmaceuticals plc (NASDAQ:AVDL) boasts of strong institutional backing

Key Insights Given the large stake in the stock by institutions, Avadel Pharmaceuticals' stock pr...

Simply Wall St. via Yahoo Finance 1 Mar 2024

Why Avadel Pharmaceuticals (AVDL) Stock Might be a Great Pick

One stock that might be an intriguing choice for investors right now is Avadel Pharmaceuticals pl...

Zacks via Yahoo Finance 14 Jan 2024

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript November 8, 2023 Avadel...

Insider Monkey via Yahoo Finance 10 Nov 2023

Avadel Pharmaceuticals PLC (AVDL): Is It Really Priced Right? An In-depth Exploration

Avadel Pharmaceuticals PLC (NASDAQ:AVDL) has recently experienced a daily gain of 2.26%, although...

GuruFocus.com via Yahoo Finance 26 Sep 2023

Avadel Pharmaceuticals plc's (NASDAQ:AVDL) institutional investors lost 7.6% last week but have...

Key Insights Significantly high institutional ownership implies Avadel Pharmaceuticals' stock pri...

Simply Wall St. via Yahoo Finance 23 Sep 2023